Medical News

RSS

TxCell demonstrates therapeutic potential of Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that TxCell researchers have achieved positive results for Col-Treg, its second product candidate from its ASTrIA platform, in a model of autoimmune uveitis, a leading cause of blindness with very limited treatment options.

28 Oct 2014

Lowering 'bad' cholesterol may help prevent aortic valve disease, study finds

An international research team led by the Research Institute of the McGill University Health Centre and Lund University has provided new evidence that aortic valve disease may be preventable.

28 Oct 2014

New model of primary care could improve health of patients with type 2 diabetes

A new model of delivering primary care studied by Keck Medicine of the University of Southern California researchers has the potential to improve the health of patients with type 2 diabetes.

28 Oct 2014

ETEC vaccine candidate provides significant protection against bacterial diarrhea

New results from a safety and immunogenicity study, which included a challenge phase to test efficacy, indicate that a live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine candidate, given in combination with a novel adjuvant, provided significant protection against disease.

28 Oct 2014

Patients who receive chest radiation for Wilms tumor face breast cancer risk later in life

A new study has found that patients who received chest radiation for Wilms tumor, a rare childhood cancer, face an increased risk of developing breast cancer later in life due to their radiation exposure.

28 Oct 2014

Study finds that mental health disorders double heart disease, stroke risks

People facing mental health challenges are significantly more likely to have heart disease or stroke, according to a study presented today at the Canadian Cardiovascular Congress.

28 Oct 2014

Leica Biosystems signs definitive agreement to purchase Devicor Medical Products

Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc.

28 Oct 2014

Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease

Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.

28 Oct 2014

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

INTEGRA reports on how respiratory drug discovery and development specialists - Pulmocide Ltd. (London, UK) are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

From INTEGRA Biosciences 28 Oct 2014

Arthritis & Osteoporosis NSW to raise awareness on importance of healthy bones this Halloween

Arthritis & Osteoporosis NSW will do anything to raise awareness of the importance of healthy bones and joints and following on from World Arthritis Day on 12 October, this Halloween, our team is getting into costume to draw attention to some chilling figures. There are plenty of scary statistics around osteoporosis fracture rates including there being 1 fracture every 3.6 minutes due to osteoporosis – ghoulish reading indeed.

28 Oct 2014

RPC1063 drug candidate has potential to improve treatment for ulcerative colitis patients

Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.

28 Oct 2014

New research suggests that TEM5 protein may be a good target for cancer therapy

Do blood vessels that feed tumors differ from other blood vessels? Fourteen years ago, experiments designed to answer that question led to the discovery of several genes that are more active in tumor-associated blood vessels than in normal blood vessels. New research now reveals the normal function of one of those genes and suggests it could be a good target for anticancer drug therapy.

28 Oct 2014

Covidien unveils new version of superDimension Navigation System software for diagnosis of lung cancer

Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.

28 Oct 2014

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.

28 Oct 2014

Imaxio awarded ANR funding to improve efficacy of vaccines for seasonal influenza

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project 'leveraging On t-cell immune resPonse To Improve influenza VACcines'.

28 Oct 2014

Cleaver Scientific helps in UK fight against Ebola

Cleaver Scientific reports that its horizontal electrophoresis equipment is being used on the frontline of the UK fight against Ebola.

From Cleaver Scientific Ltd 27 Oct 2014

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, has entered into an exclusive license agreement with Norgine B.V., a European specialist pharmaceutical company, for the commercialization of MuGard in Australia and New Zealand.

27 Oct 2014

Practice Fusion releases new mobile-optimized EHR platform for medical professionals

Practice Fusion, the nation's largest cloud-based electronic health records (EHR) platform, today launched a new EHR for Practice Fusion's community of more than 112,000 medical professionals. Practice Fusion received more than 20,000 requests from users for a mobile-optimized EHR experience for the Apple iPad, iPad Mini and Android tablets.

27 Oct 2014

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.

27 Oct 2014

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation.

27 Oct 2014

Medical News

TxCell demonstrates therapeutic potential of Col-Treg for treatment of autoimmune uveitis

Lowering 'bad' cholesterol may help prevent aortic valve disease, study finds

New model of primary care could improve health of patients with type 2 diabetes

ETEC vaccine candidate provides significant protection against bacterial diarrhea

Patients who receive chest radiation for Wilms tumor face breast cancer risk later in life

Study finds that mental health disorders double heart disease, stroke risks

Leica Biosystems signs definitive agreement to purchase Devicor Medical Products

Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

Arthritis & Osteoporosis NSW to raise awareness on importance of healthy bones this Halloween

RPC1063 drug candidate has potential to improve treatment for ulcerative colitis patients

New research suggests that TEM5 protein may be a good target for cancer therapy

Covidien unveils new version of superDimension Navigation System software for diagnosis of lung cancer

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Imaxio awarded ANR funding to improve efficacy of vaccines for seasonal influenza

Cleaver Scientific helps in UK fight against Ebola

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

Practice Fusion releases new mobile-optimized EHR platform for medical professionals

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News